<DOC>
	<DOCNO>NCT01101685</DOCNO>
	<brief_summary>This study aim improve understand people low mood negative feeling ( know dysphoric ) may different people normal mood feeling ( nondysphoric ) respond variety social emotional information . The study look pattern activity people ' brain situation ( present battery test ) treatment medicine ( escitalopram ) placebo . The result study help gather information effectiveness various test use study detecting change due treatment antidepressant . Half volunteer take part study dysphoric ( mildly depress ) whilst half volunteer healthy volunteer . It hop result study provide guidance assess effectiveness new medicine potentially help treatment depression .</brief_summary>
	<brief_title>Neural Responses Dysphoria : Modulation Pharmacological Probe</brief_title>
	<detailed_description />
	<mesh_term>Citalopram</mesh_term>
	<mesh_term>Dexetimide</mesh_term>
	<criteria>Male female age 18 45 year , inclusive Randomisation visit . Fluent English speaker . Beck Depression Inventory ( BDI ) score 05 ≥10 Screening Randomisation visit . Hamilton Depression Rating Scale ( HAMD ) score &lt; 24 Screening Randomisation visit . Healthy Screening visit determine physician . Female participant surgically sterile abstinent , sexually active , practise effective method birth control . Acceptable weight define body mass index ( BMI ) range 18 30 kg/m² , inclusive . Normotensive sitting ( 5 minute ) blood pressure range 100 140 mmHg systolic , inclusive 60 90 mmHg diastolic , inclusive Screening . Non smoker light smoker ( ≤ 5 cigarette per day ) . Participants must sign Informed Consent Form . Participants provide genetic sample must sign DNA consent . History alcohol substance dependence within last 6 month . Consumption large amount caffeinated drink . Relevant history presence upon clinical examination , cardiac , ophthalmologic , pulmonary , endocrine ( diabetes ) , cancer , blood disease , gastrointestinal , hepatic renal disease condition . History presence significant neurological psychiatric condition . Exceptions participant history depression dysphoric group . Participants generalise anxiety disorder anxiety disorder may enter discretion Investigator . Participants , opinion Investigator , risk suicide . Any use sedative hypnotic , include benzodiazepine , zolpidem zopiclone within last 3 month prior Randomisation visit . Any use medication depression last three month prior Randomisation visit . Have receive prescribed medication within 14 day prior Randomisation visit ( apart contraceptive pill ) . Have receive overthecounter ( OTC ) medicine within 48 hour prior Randomisation visit . Have receive experimental drug and/or use experimental medical device within 30 day Randomisation visit within period le 5 time drug 's half life , whichever longer . If female : pregnant try get pregnant currently breast feed . History , current condition , migraine headache undergone operation head . Significant hearing impairment . Significant visual impairment history ocular treatment . Lefthanded . Previous experience emotional test battery experimental procedure . Unable comply magnetic resonance ( MR ) Patient Declaration . Involvement emergency ( medically emergent ) situation Screening Randomisation visit . Surgery Screening Randomisation visit . Unable unwilling comply study procedure .</criteria>
	<gender>All</gender>
	<minimum_age>18 Years</minimum_age>
	<maximum_age>45 Years</maximum_age>
	<verification_date>June 2011</verification_date>
	<keyword>non-dysphoric</keyword>
	<keyword>Dysphoric</keyword>
</DOC>